Bullish indicating open at $55-$60, IPO prices at $37
In a recent transaction, Nina Capital Holdings Inc., a ten percent owner, acquired 40,000 shares of PetMed Express Inc. (NASDAQ:PETS) on December 6. The shares were bought at an average price of $5.55, amounting to a total purchase value of $222,000. The timing appears favorable, as InvestingPro data shows the stock has surged 32% in the past week, with shares now trading at $6.58. Following this acquisition, Nina Capital Holdings, along with Moises Tache Galante and his spouse, Stephannie Matz Zyman, now jointly hold 2,118,000 shares of PetMed Express, representing a significant portion of the company's $136.29 million market capitalization. The purchase reflects a continued investment interest in the retail drug store company, which is headquartered in Delray Beach, Florida. InvestingPro analysis reveals the stock has demonstrated strong momentum with a 57% gain over the past six months. Subscribers can access 12 additional ProTips and a comprehensive Pro Research Report for deeper insights into PETS's valuation and growth prospects.
In other recent news, PetMed Express has been active with significant developments. The company implemented a limited duration shareholder rights plan to protect the interests of all shareholders and prevent disproportionate control without a fair premium. This move comes as the board perceives the company's stock as undervalued, not reflecting the true worth of the business or its future growth prospects.
In the earnings realm, PetMed Express reported a net income increase to $2.3 million, or $0.11 per diluted share, despite a 16% drop in sales to $60 million in its Q2 2025. The company also acquired approximately 77,000 new customers, attributed to operational improvements enhancing the customer service experience.
Further, the company is preparing for a significant marketing push for the holiday season and the launch of a new content site. These initiatives are part of its strategy to become a leader in consumer pet healthcare. Despite a decline in sales due to consumer pressure and expected lower margins in Q3 due to increased promotional activities, PetMed Express is committed to navigating the current market landscape. These are some of the recent developments in the company's journey.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.